ChinaDaily Briefs

Daily Brief China: Tencent, Bama Tea, Duality Biotherapeutics, New World Development, Zhipu AI and more

In today’s briefing:

  • Dividends, Volatility, and Profits: HSI and HSCEI Heavyweights Reveal Results, 17 – 21 March
  • Bama Tea Pre-IPO – Fourth Attempt to Go Public
  • Duality Biotherapeutics (映恩生物) Pre-IPO: PHIP Updates Show Slight Improvements
  • Lucror Analytics – Morning Views Asia
  • Chinese Startup Zhipu AI Raises $207 Million Funding in Less Than a Month


Dividends, Volatility, and Profits: HSI and HSCEI Heavyweights Reveal Results, 17 – 21 March

By Gaudenz Schneider

  • Over a dozen Hang Seng Index companies (31% of index weight) report next week, along with significant portions of HSCEI (38%) and Hang Seng TECH Index (32%) components.
  • The four index heavy-weights Xiaomi Corp, Tencent, China Mobile, and Meituan all report next week.
  • Weekly options expiring March 21 provide targeted instruments for traders looking to capitalize on earnings-related price movements.

Bama Tea Pre-IPO – Fourth Attempt to Go Public

By Troy Wong

  • Bama Tea (BT) is looking to raise at least US$100m in its upcoming Hong Kong IPO.
  • BT mainly grew through franchising. Its broad portfolio boosts market reach. A shift to online sales and stable tea prices may improve gross margins.
  • BT needs capital for expansion but faces challenges: a fragmented, slow-growing industry, declining franchise earnings, weak 9M24 tea-leaf sales, supplier/customer concentration, and this being BT’s fourth attempt at going public.

Duality Biotherapeutics (映恩生物) Pre-IPO: PHIP Updates Show Slight Improvements

By Ke Yan, CFA, FRM

  • Duality Biotherapeutics, a China-based clinical-stage biotechnology company, plans to raise up to US$300m via a Hong Kong listing.
  • The company has passed the hearing for the listing and filed a new version of the prospectus.
  • We look at the difference between previous filing and current filing.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: New World Development
  • In the US, the February final demand PPI came in lower than expected at 0.0% m-o-m (0.3% e / 0.6% revised p) and 3.2% y-o-y (3.3% e / 3.7% revised p). PPI excluding food and energy fell 0.1% m-o-m, but was up 3.4% y-o-y (3.5% e / 3.8% revised p).
  • The PPI was weighed down by a 1% decline in trade services. That said, categories that go into the PCE price index (the Fed’s preferred measure of inflation) were largely firmer, which could contribute to a high PCE print (vs. the CPI) later this month.

Chinese Startup Zhipu AI Raises $207 Million Funding in Less Than a Month

By Caixin Global

  • Zhipu AI, a leading Chinese generative artificial intelligence (AI) start-up, has raised 500 million yuan ($69 million) in new funding less than a month after securing 1 billion yuan ($138 million) in its previous round.
  • On Thursday, Huafa Group, a conglomerate backed by the Zhuhai city government in Guangdong province, announced its investment in Zhipu AI, to drive technical innovation and business development for Zhipu’s foundation model, GLM.
  • The same day, Huafa and the Zhuhai National High-Tech Industrial Development Zone signed a cooperation agreement with Zhipu to speed up the industrial application of its AI models.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars